FDA’s Office Of Regulatory Policy To Be Headed By Covington & Burling Alum
This article was originally published in The Pink Sheet Daily
Executive Summary
Grail Sipes, who joined FDA three years ago as a senior regulatory counsel, has been named permanent director of ORP; Department of Justice’s Deputy Inspector General appointed to head Office of Compliance.
You may also be interested in...
Top US FDA Drug Policy Leader Leaving For White House Detail
Grail Sipes, CDER deputy center director for regulatory policy, will move to the Executive Office of the President next month.
FDA Again Taps Compliance Director For Globalization Post
Howard Sklamberg, currently director of the CDER Office of Compliance, will take over the Office of Global Regulatory Operations and Policy after a year as CDER compliance office director.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.